Showing results (321-330 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|February 9, 2000
Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trialsA M SenderowiczInvestigational New Drugs|June 1, 2000
Development of target-based antineoplastic agentsW M Stadler, M J RatainInvestigational New Drugs|April 12, 2000
Activation-induced apoptosis of peripheral lymphocytes treated with 7-hydroxystaurosporine, UCN-01H Fukumoto, T Tamura, Y Kamiya, et al.Investigational New Drugs|April 12, 2000
Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activityL Neckers, T W Schulte, E MimnaughInvestigational New Drugs|April 12, 2000
Matrix metalloproteinase inhibitors: applications in oncologyD Yip, A Ahmad, C S Karapetis, et al.Investigational New Drugs|April 12, 2000
Oral topoisomerase 1 inhibitors in adult patients: present and futureH A Gelderblom, M J DE Jonge, A Sparreboom, et al.Investigational New Drugs|April 12, 2000
Toward checkmate: biology and breast cancer therapy for the new millenniumK D Miller, G W SledgeInvestigational New Drugs|January 22, 2021
Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumorsQuincy Siu-Chung Chu, Nathaniel Bouganim, Caroline Fortier, et al.Investigational New Drugs|September 15, 2019
Synthesis and cellular effects of novel 1,3,5-triazine derivatives in DLD and Ht-29 human colon cancer cell linesAgnieszka Wróbel, Beata Kolesińska, Justyna Frączyk, et al.Investigational New Drugs|September 8, 2019
A new series of acetohydroxamates shows in vitro and in vivo anticancer activity against melanomaGabriela C Segat, Camila G Moreira, Evelyn C Santos, et al.Pageof 372